Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation.

Hanna LenhoffBörje DarpöAlex PageJean Philippe CoudercPer TornvallMats Frick

Published in: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (2021)

Twenty-four-hour Holter recordings with QT-measurement immediately after CV demonstrated that one in five patients on sotalol had >20% of all heart beats with prolonged QTc >500 ms, especially during night-time. The QTc diurnal variation was retained in patients on β-blockade or a potent class III anti-arrhythmic drug with β-blocking properties.

Keyphrases

atrial fibrillation
end stage renal disease
newly diagnosed
heart failure
prognostic factors
blood pressure
mass spectrometry
drug induced
venous thromboembolism
catheter ablation
patient reported
anti inflammatory